Receptors as novel inhibitors of vascular endothelial growth fac

Details Receptors as novel inhibitors of vascular endothelial growth fac Receptors as novel inhibitors of vascular endothelial growth fac

1996-05-07

2000-08-08

Spector, Lorraine

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

530300, 536 231, 536 234, 4353201, 435325, 435366, 4352523, 43525411, C07K 1471, C12N 510, C12N 1509, C12N 1511

Patent

active

06100071&

ABSTRACT:
The present invention is directed to novel chimeric VEGF receptor proteins comprising amino acid sequences derived from the vascular endothelial growth factor (VEGF) receptors flt-1 and KDR, including the murine homologue to the human KDR receptor FLK-1, wherein said chimeric VEGF receptor proteins bind to VEGF and antagonize the endothelial cell proliferative and angiogenic activity thereof. The present invention is also directed to nucleic acids and expression vectors encoding these chimeric VEGF receptor proteins, host cells harboring such expression vectors, pharmaceutically acceptable compositions comprising such proteins, methods of preparing such proteins and to methods utilizing such proteins for the treatment of conditions associated with undesired vascularization.

REFERENCES:
patent: 4456550 (1984-06-01), Dvorak et al.
patent: 5008196 (1991-04-01), Connolly et al.
patent: 5036003 (1991-07-01), Olander et al.
patent: 5185438 (1993-02-01), Lemischka
patent: 5240848 (1993-08-01), Keck et al.
Ferrara, N., et al., "The Vascular Endothelial Growth Factor Family of Polypeptides," Journal of Cellular Biochemistry, 47:211-218 (1991).
Tischer, E., et al., "The Human Gene for Vascular Endothelial Growth Factor," The Journal of Biological Chemistry, 266(18):11947-11954 (1991).
Tischer, E., et al., "Vascular Endothelial Growth Factor: A New Member of the Platelet-Derived Growth Factor Gene Family," Biochemical and Biophysical Research Communications, 165(3):1198-1206 (1989).
Chamow, S.M., et al. "Immunoadhesins: principles and applications", Tibtech, vol. 14, pp. 52-60 (1996).
Cunningham, S.A., "Identification of the Extracellular Domains of Flt-1 That Mediate Ligand Interactions", Biochemical and Biophysical Research Communications, 231: pp. 596-599 (1997).
Davis-Smyth, T., et al. "The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade", The EMBO Journal, vol. 15, No. 18, pp. 4919-4927 (1996).
Creighton, Proteins, WH Freeman and Company: New York, NY, pp. 223-227, 1984.
Schulz et al., Principles of Protein Structure, Springer-Verlag: New York, NY, pp. 14-16, 1979.
Ailello et al., Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins, Proc. Natl. Acad. Sci. USA, 92(23): 10457-10461, Nov. 1995.
Park et al., Placenta growth factor, J. Biol. Chem., 269(41): 25646-25654, Oct. 1994.
Plowman et al., Receptor tyrosine kinases as targets for drug intervention, DN&P, 7(6): 334-339, Aug. 1994.
Heidaran et al., Beta PDGFR-IgG chimera demonstrates that human beta PDGFR Ig-like domains 1 to 3 are sufficient for high affinity PDGF BB binding, FASEB J., 9: 140-145, 1995.
Cheon et al., High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains, Proc. Natl. Acad. Sci. USA, 91: 989-993, Feb. 1994.
Klein, Immunogy: The Science of Self-Nonself Discrimination, Wiley-Interscience: New York, NY, pp. 160-161 and 190-191, 1982.
Rockwell et al., In vitro neutralization of vascular endothelial growth factor activation of flk-1 by monoclonal antibody, Mol. Cell. Differ., 3(1): 91-109, 1995.
Kendall et al., Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor, Proc. Natl. Acad. Sci. USA, 90: 10705-10709, Nov. 1993.

Affiliated with

Also associated with

Rating

Receptors as novel inhibitors of vascular endothelial growth fac does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Receptors as novel inhibitors of vascular endothelial growth fac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptors as novel inhibitors of vascular endothelial growth fac will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1149113